For instance, loading PD-L1 siRNA or small-molecule degraders has been shown to reverse the immunosuppressive state in hepatocellular carcinoma models post-radiofrequency ablation (iRFA), while simultaneously restoring the anti-tumor function of cytotoxic T cells [124]. Here, CD274 is linked to neoplasm.